KT&G Unveils Duty-Free Exclusive Cigarette Line 'Raison Ionia' in Three Flavors

Nov.18.2024

KT&G Unveils Duty-Free Exclusive Cigarette Line 'Raison Ionia' in Three Flavors

KT&G launches the airport-exclusive "raison ionia" series, available in duty-free stores with three low-tar, low-nicotine flavors. the brand director states their commitment to introducing products reflecting diverse consumer needs.

According to a report by N.News on November 18th, Korean Tobacco (KT&G) announced the official launch of three new products designed specifically for duty-free shops called "Raison ionia" on the 18th.

According to reports, the "Raison ionia" series of cigarettes contains 4% tobacco leaf, and its packaging design is based on the "R platform," effectively showcasing the brand's uniqueness. The three new products released are Mystic Purple, Ocean Blue, and Summer Red, each with tar and nicotine content of 0.1mg and 0.01mg. These products can be purchased at duty-free stores in six airports including Incheon, Gimpo, Gimhae, Daegu, and Jeju.

KT&G's domestic brand manager Song Seung-Chul said: "In order to provide airport consumers with a special experience, we are launching three duty-free exclusive products called "Raison ionia". In the future, we will continue to enhance brand satisfaction by offering products that reflect diverse consumer needs and trends."

KT&G released a limited edition product called "RAISON ionia 3 in 1" in September this year, which includes three new varieties in one pack.

References:

[1] KT&G, 면세 전용 제품 '레종 이오니아' 3종 정식 출시

Also Read:

[1] KT&G Q3: Profits Drop 28% to $200M as Tobacco Sales Hit Record

[2] KT&G introduces new pod product 'FIT Change UNIQ' for 'Lil Solid'

[3] KT&G Launches New "REAL" Series for HNB Device

[4] KT&G Launches Upgraded HTP "Lil Solid 3.0" with New Features

[5] KT&G Launches Limited Edition "Raison Ionia 3 in 1" at Airports

[6] KT&G Dominates HNB e-Cigarette Market with Lil Series

[7] KT&G Expands Sales Network for 'Lil Able 2.0'

[8] South Korea's Tobacco Export to Russia Reaches Record High

#Traditional tobacco #Asia #Products #South Korea

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States

EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States

EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director

Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026

At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office

Sep.16 by 2Firsts Perspectives

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene

American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.

Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings

Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings

During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup

Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024

Related Topics

HEADLINE News Company

Related Read

EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States

EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026

2Firsts Perspectives

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene

Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings

Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup